H tr trong iu tr cc bnh l lin quan n ri lon mch ngoi vi, mch vnh v cc ri lon huyt hc: Ci thin cc thng s huyt ng ca h tun hon ln v nh, gip ko di khong cch i b khng cm thy au cc bnh nhn b tc ng mch chi di
Summary GLP-1/GCG RAs have consistently shown a reduction in liver fat content independent of weight loss, positioning them as a promising treatment for MASLD and MASH
In clinical trials, people taking tirzepatide were less likely to stop treatment because of gastrointestinal side effects than those taking semaglutide, suggesting that some people may find Zepbound easier to stay on
This warning is based on the results from rodent studies where this medication increased the risk of developing thyroid tumors in rodents
Nystrom T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahrn B, Sjholm A